Key facts
- It has raised $340K; the latest was Seed Round in Dec 2025.
- Notable investors include Tech Incubator Program for Startup, MYSC Co.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Perioneer
- ·The full record, as it builds
Funding rounds
No funding rounds for Perioneer are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Perioneer
Developer of customized immune-based treatments intended for radical periodontitis. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2024
- Ownership
- Privately Held (backing)
Perioneer doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Perioneer shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Perioneer in its N-PORT filings yet. We sweep new filings monthly.